{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:55:52Z","timestamp":1766022952448,"version":"3.48.0"},"reference-count":39,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/twvi9995","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T04:02:40Z","timestamp":1743134560000},"page":"2005-2013","source":"Crossref","is-referenced-by-count":0,"title":["Effects of labetalol plus magnesium sulfate on brain symptoms and pregnancy outcomes in hypertensive disorders of pregnancy"],"prefix":"10.62347","volume":"17","author":[{"given":"Xiaolan","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41574-022-00734-y","article-title":"A global view of hypertensive disorders and diabetes mellitus during pregnancy","volume":"18","author":"Jiang","year":"2022","unstructured":"Jiang L, Tang K, Magee LA, von Dadelszen P, Ekeroma A, Li X, Zhang E and Bhutta ZA. A global view of hypertensive disorders and diabetes mellitus during pregnancy. Nat Rev Endocrinol 2022; 18: 760-775.","journal-title":"Nat Rev Endocrinol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"831297","DOI":"10.3389\/fcvm.2022.831297","article-title":"Gestational diabetes mellitus and preeclampsia: correlation and influencing factors","volume":"9","author":"Yang","year":"2022","unstructured":"Yang Y and Wu N. Gestational diabetes mellitus and preeclampsia: correlation and influencing factors. Front Cardiovasc Med 2022; 9: 831297.","journal-title":"Front Cardiovasc Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"12708","DOI":"10.1038\/s41598-021-92189-w","article-title":"Earlier onset of proteinuria or hypertension is a predictor of progression from gestational hypertension or gestational proteinuria to preeclampsia","volume":"11","author":"Morikawa","year":"2021","unstructured":"Morikawa M, Mayama M, Noshiro K, Saito Y, Nakagawa-Akabane K, Umazume T, Chiba K, Kawaguchi S and Watari H. Earlier onset of proteinuria or hypertension is a predictor of progression from gestational hypertension or gestational proteinuria to preeclampsia. Sci Rep 2021; 11: 12708.","journal-title":"Sci Rep"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11906-020-01070-0","article-title":"Hypertension during pregnancy","volume":"22","author":"Agrawal","year":"2020","unstructured":"Agrawal A and Wenger NK. Hypertension during pregnancy. Curr Hypertens Rep 2020; 22: 64.","journal-title":"Curr Hypertens Rep"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"7897189","DOI":"10.1155\/2018\/7897189","article-title":"Racial\/ethnic, nativity, and sociodemographic disparities in maternal hypertension in the united states, 2014-2015","volume":"2018","author":"Singh","year":"2018","unstructured":"Singh GK, Siahpush M, Liu L and Allender M. Racial\/ethnic, nativity, and sociodemographic disparities in maternal hypertension in the united states, 2014-2015. Int J Hypertens 2018; 2018: 7897189.","journal-title":"Int J Hypertens"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ajog.2020.03.016","article-title":"Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis","volume":"223","author":"Bellos","year":"2020","unstructured":"Bellos I, Pergialiotis V, Papapanagiotou A, Loutradis D and Daskalakis G. Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. Am J Obstet Gynecol 2020; 223: 525-537.","journal-title":"Am J Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry Baird S, Magee LA, Rana S, Vermunt JV and August P; American Heart Association Council on Hypertension; Council on the Kidney in Cardiovascular Disease, Kidney in Heart Disease Science Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Stroke Council. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the american heart association. Hypertension 2022; 79: e21-e41.","DOI":"10.1161\/HYP.0000000000000208"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Abalos E, Duley L, Steyn DW and Gialdini C. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2018; 10: CD002252.","DOI":"10.1002\/14651858.CD002252.pub4"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/SLE.0000000000000571","article-title":"The impact of magnesium sulfate on pain control after laparoscopic cholecystectomy: a meta-analysis of randomized controlled studies","volume":"28","author":"Chen","year":"2018","unstructured":"Chen C and Tao R. The impact of magnesium sulfate on pain control after laparoscopic cholecystectomy: a meta-analysis of randomized controlled studies. Surg Laparosc Endosc Percutan Tech 2018; 28: 349-353.","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"ref9","unstructured":"Zhang X, Cheng X, Yang T and Zhao Q. Efficacy of magnesium sulfate combined with nifedipine for pregnancy-induced hypertension syndrome and its relation to glucose and lipid metabolism. Am J Transl Res 2023; 15: 5940-5948."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s12028-014-9964-0","article-title":"Prophylactic magnesium sulfate for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"21","author":"Reddy","year":"2014","unstructured":"Reddy D, Fallah A, Petropoulos JA, Farrokhyar F, Macdonald RL and Jichici D. Prophylactic magnesium sulfate for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit Care 2014; 21: 356-364.","journal-title":"Neurocrit Care"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.preghy.2021.03.002","article-title":"Current state of affairs: a study regarding diagnosis, treatment and use of home blood pressure monitoring for hypertension in pregnancy","volume":"24","author":"Nash","year":"2021","unstructured":"Nash CM and Shetty N. Current state of affairs: a study regarding diagnosis, treatment and use of home blood pressure monitoring for hypertension in pregnancy. Pregnancy Hypertens 2021; 24: 96-99.","journal-title":"Pregnancy Hypertens"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5152\/alphapsychiatry.2024.231342","article-title":"Efficacy of magnesium sulfate and labetalol in the treatment of pregnancy-induced hypertension and its effect on anxiety and depression: a retrospective cohort study","volume":"25","author":"Wang","year":"2024","unstructured":"Wang S, Zhang J, Zhu T, Xie X, Xia X and Li Y. Efficacy of magnesium sulfate and labetalol in the treatment of pregnancy-induced hypertension and its effect on anxiety and depression: a retrospective cohort study. Alpha Psychiatry 2024; 25: 243-248.","journal-title":"Alpha Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"536","DOI":"10.5603\/gpl.97752","article-title":"Effects of intravenous nicardipine followed by oral labetalol in combination with nifedipine controlled-release tablet on severe peripartum hypertension","volume":"95","author":"Lan","year":"2024","unstructured":"Lan L, Yan Y, Qi H, Qin J, Li L, Gan S, Zhang R and Zhang Y. Effects of intravenous nicardipine followed by oral labetalol in combination with nifedipine controlled-release tablet on severe peripartum hypertension. Ginekol Pol 2024; 95: 536-543.","journal-title":"Ginekol Pol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40292-023-00582-5","article-title":"Hypertension in pregnancy: a diagnostic and therapeutic overview","volume":"30","author":"Cifkova","year":"2023","unstructured":"Cifkova R. Hypertension in pregnancy: a diagnostic and therapeutic overview. High Blood Press Cardiovasc Prev 2023; 30: 289-303.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/jhn.12654","article-title":"The efficacy of the dietary approaches to stop hypertension diet with respect to improving pregnancy outcomes in women with hypertensive disorders","volume":"32","author":"Jiang","year":"2019","unstructured":"Jiang F, Li Y, Xu P, Li J, Chen X, Yu H, Gao B, Xu B, Li X and Chen W. The efficacy of the dietary approaches to stop hypertension diet with respect to improving pregnancy outcomes in women with hypertensive disorders. J Hum Nutr Diet 2019; 32: 713-718.","journal-title":"J Hum Nutr Diet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.clp.2020.08.011","article-title":"Hypertensive disorders of pregnancy","volume":"47","author":"Booker","year":"2020","unstructured":"Booker WA. Hypertensive disorders of pregnancy. Clin Perinatol 2020; 47: 817-833.","journal-title":"Clin Perinatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/GRF.0b013e31825d7b68","article-title":"Headache and neurological disease in pregnancy","volume":"55","author":"Pearce","year":"2012","unstructured":"Pearce CF and Hansen WF. Headache and neurological disease in pregnancy. Clin Obstet Gynecol 2012; 55: 810-828.","journal-title":"Clin Obstet Gynecol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1111\/jog.15295","article-title":"Risk factors and adverse pregnancy outcomes in older pregnant women with hypertensive disorders of pregnancy","volume":"48","author":"Zhang","year":"2022","unstructured":"Zhang H and Wang W. Risk factors and adverse pregnancy outcomes in older pregnant women with hypertensive disorders of pregnancy. J Obstet Gynaecol Res 2022; 48: 1710-1720.","journal-title":"J Obstet Gynaecol Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/jama.2022.19590","article-title":"Treatment of hypertension: a review","volume":"328","author":"RM","year":"2022","unstructured":"Carey RM, Moran AE and Whelton PK. Treatment of hypertension: a review. JAMA 2022; 328: 1849-1861.","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00404-024-07731-8","article-title":"Using doppler ultrasound to assess fetal cardiac function and pregnancy outcomes in obstetric antiphospholipid syndrome pregnancies: a case-control study","volume":"310","author":"Wang","year":"2024","unstructured":"Wang B, Wang Q, Yu D, Zhang N, Wang Z, Sun X, Liu M and Su X. Using doppler ultrasound to assess fetal cardiac function and pregnancy outcomes in obstetric antiphospholipid syndrome pregnancies: a case-control study. Arch Gynecol Obstet 2024; 310: 2461-2468.","journal-title":"Arch Gynecol Obstet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3897\/folmed.63.e56489","article-title":"High-sensitivity CRP levels in women with gestational hypertension, preeclampsia and in normotensive pregnant women and its correlations","volume":"63","author":"Gencheva","year":"2021","unstructured":"Gencheva DG, Nikolov FP, Uchikova EH, Mihaylov RD, Pencheva BG and Ivanova KI. High-sensitivity CRP levels in women with gestational hypertension, preeclampsia and in normotensive pregnant women and its correlations. Folia Med (Plovdiv) 2021; 63: 511-518.","journal-title":"Folia Med (Plovdiv)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccl.2020.09.005","article-title":"Hypertensive disorders of pregnancy","volume":"39","author":"Khedagi","year":"2021","unstructured":"Khedagi AM and Bello NA. Hypertensive disorders of pregnancy. Cardiol Clin 2021; 39: 77-90.","journal-title":"Cardiol Clin"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.14310\/horm.2002.1582","article-title":"Pregnancy-induced hypertension","volume":"14","author":"Kintiraki","year":"2015","unstructured":"Kintiraki E, Papakatsika S, Kotronis G, Goulis DG and Kotsis V. Pregnancy-induced hypertension. Hormones (Athens) 2015; 14: 211-223.","journal-title":"Hormones (Athens)"},{"key":"ref24","unstructured":"Wu Y, Wang DJ, Zhang Y, Zhang YX and Zhang R. Regulation of magnesium sulfate combined with nifedipine and labetalol on disease-related molecules in serum and placenta in the treatment of preeclampsia. Eur Rev Med Pharmacol Sci 2020; 24: 5062-5070."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s10194-017-0816-0","article-title":"Headache and pregnancy: a systematic review","volume":"18","author":"Negro","year":"2017","unstructured":"Negro A, Delaruelle Z, Ivanova TA, Khan S, Ornello R, Raffaelli B, Terrin A, Reuter U and Mitsikostas DD; European Headache Federation School of Advanced Studies (EHF-SAS). Headache and pregnancy: a systematic review. J Headache Pain 2017; 18: 106.","journal-title":"J Headache Pain"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.4103\/ija.IJA_475_18","article-title":"Hypertensive disorders in pregnancy","volume":"62","author":"Upadya","year":"2018","unstructured":"Upadya M and Rao ST. Hypertensive disorders in pregnancy. Indian J Anaesth 2018; 62: 675-681.","journal-title":"Indian J Anaesth"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3135043","DOI":"10.1155\/2021\/3135043","article-title":"Clinical evaluation of pinggan yiqi yangshen recipe combined with labetalol hydrochloride and magnesium sulfate in the treatment of PIH","volume":"2021","author":"Li","year":"2021","unstructured":"Li P, Zhao J, Gao P and Qu H. Clinical evaluation of pinggan yiqi yangshen recipe combined with labetalol hydrochloride and magnesium sulfate in the treatment of PIH. Evid Based Complement Alternat Med 2021; 2021: 3135043.","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1753944717746613","article-title":"Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients","volume":"12","author":"MF","year":"2018","unstructured":"Gaynor MF, Wright GC and Vondracek S. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients. Ther Adv Cardiovasc Dis 2018; 12: 7-15.","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s13224-017-1053-9","article-title":"Comparison of efficacy and safety of intravenous labetalol versus hydralazine for management of severe hypertension in pregnancy","volume":"68","author":"Patel","year":"2018","unstructured":"Patel P, Koli D, Maitra N, Sheth T and Vaishnav P. Comparison of efficacy and safety of intravenous labetalol versus hydralazine for management of severe hypertension in pregnancy. J Obstet Gynaecol India 2018; 68: 376-381.","journal-title":"J Obstet Gynaecol India"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Xiang C, Zhou X and Zheng X. Magnesium sulfate in combination with nifedipine in the treatment of pregnancy-induced hypertension. Pak J Med Sci 2020; 36: 21-25.","DOI":"10.12669\/pjms.36.2.706"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"He G, Chen Y, Chen M, He G and Liu X. Efficacy and safety of low dose aspirin and magnesium sulfate in the treatment of pregnancy induced hypertension: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020; 99: e22801.","DOI":"10.1097\/MD.0000000000022801"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3892\/etm.2020.9406","article-title":"Effect of magnesium sulfate combined with labetalol on serum sFlt-1\/PlGF ratio in patients with early-onset severe pre-eclampsia","volume":"20","author":"Wang","year":"2020","unstructured":"Wang Y, Bao J and Peng M. Effect of magnesium sulfate combined with labetalol on serum sFlt-1\/PlGF ratio in patients with early-onset severe pre-eclampsia. Exp Ther Med 2020; 20: 276.","journal-title":"Exp Ther Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"7951342","DOI":"10.1155\/2022\/7951342","article-title":"Uterine ultrasound doppler hemodynamics of magnesium sulfate combined with labetalol in the treatment of pregnancy-induced hypertension using empirical wavelet transform algorithm","volume":"2022","author":"Liu","year":"2022","unstructured":"Liu C, Wang F and Yin X. Uterine ultrasound doppler hemodynamics of magnesium sulfate combined with labetalol in the treatment of pregnancy-induced hypertension using empirical wavelet transform algorithm. Comput Intell Neurosci 2022; 2022: 7951342.","journal-title":"Comput Intell Neurosci"},{"key":"ref34","unstructured":"Farzadnia M, Ayatollahi H, Hasan-Zade M and Rahimi HR. A comparative study of serum level of vascular cell adhesion molecule-1 (sVCAM-1), intercellular adhesion molecule-1 (ICAM-1) and high sensitive C - reactive protein (hs-CRP) in normal and pre-eclamptic pregnancies. Iran J Basic Med Sci 2013; 16: 689-693."},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Kong D, Wang H, Liu Y, Li H, Wang H and Zhu P. Correlation between the expression of inflammatory cytokines IL-6, TNF-alpha and hs-CRP and unfavorable fetal outcomes in patients with pregnancy-induced hypertension. Exp Ther Med 2018; 16: 1982-1986.","DOI":"10.3892\/etm.2018.6393"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3892\/etm.2024.12554","article-title":"Effects of magnesium sulfate combined with labetalol on inflammatory stress and pregnancy outcome of patients with gestational hypertension","volume":"27","author":"Gu","year":"2024","unstructured":"Gu Z, Gu W, Zhang G, Tang Y, Wang M, Guo Y and Zhou L. Effects of magnesium sulfate combined with labetalol on inflammatory stress and pregnancy outcome of patients with gestational hypertension. Exp Ther Med 2024; 27: 266.","journal-title":"Exp Ther Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s10877-023-01006-4","article-title":"Evaluation of intravenous infusion of labetalol versus magnesium sulfate on cerebral hemodynamics of preeclampsia patients with severe features using transcranial doppler","volume":"37","author":"Mowafy","year":"2023","unstructured":"Mowafy SMS and Medhat MM. Evaluation of intravenous infusion of labetalol versus magnesium sulfate on cerebral hemodynamics of preeclampsia patients with severe features using transcranial doppler. J Clin Monit Comput 2023; 37: 951-961.","journal-title":"J Clin Monit Comput"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/01.ogx.0000238670.29492.84","article-title":"Cerebral hemodynamics in preeclampsia: cerebral perfusion and the rationale for an alternative to magnesium sulfate","volume":"61","author":"MA","year":"2006","unstructured":"Belfort MA, Clark SL and Sibai B. Cerebral hemodynamics in preeclampsia: cerebral perfusion and the rationale for an alternative to magnesium sulfate. Obstet Gynecol Surv 2006; 61: 655-665.","journal-title":"Obstet Gynecol Surv"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/3\/ajtr0161531.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:50:59Z","timestamp":1766022659000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/3\/ajtr0161531.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/twvi9995","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2025]]}}}